Pfizer drug found with serious side effect

Nov 01, 2006

U.S. pharmaceutical company Pfizer Inc. says clinical trials of its heart medication torcetrapib suggest the drug has a potentially serious side effect.

Pfizer says the trials involving what is viewed as the company's most important pending drug confirm its increases blood pressure, The New York Times reported.

Analysts say Pfizer, the world's largest drug company. Expects torcetrapib to replace the $13 billion in annual sales from the cholesterol-lowering drug Lipitor, which loses patent protection in 2010.

Pfizer's stock dropped 2 percent after the Tuesday announcement by the company, which has been researching torcetrapib for a decade and is spending $800 million to develop it, the Times said.

Pfizer said it still expects to submit the medicine for federal approval sometime during the second half of next year, with an approval possible in 2008.

Pfizer hopes to show a combination of torcetrapib and Lipitor can reduce the formation of arterial plaque.

Copyright 2006 by United Press International

Explore further: Ombitasvir/paritaprevir/r in hepatitis C: Indication of added benefit in certain patients

Related Stories

New drug produces steep drop in bad cholesterol

Nov 17, 2010

(AP) -- An experimental drug boosted good cholesterol so high and dropped bad cholesterol so low in a study that doctors were stunned and voiced renewed hopes for an entirely new way of preventing heart attacks ...

More 'good' cholesterol is not always good for your health

May 25, 2010

(PhysOrg.com) -- We've all heard about the importance of raising HDL, or the so-called "good" cholesterol, and lowering LDL, or "bad" cholesterol, to improve heart health. While we've come to assume HDL cholesterol ...

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

May 22, 2015

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.